HR Execs on the Move

Mark Ross and Co.

www.markross.com

 
Mark Ross & Co., Inc is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Infusion Express

Infusion Express offers the IV therapy you need in a place and time that works for you. We work around your schedule by offering weekday, evening and Saturday appointments. All of our patients are treated in private suites fully equipped with WiFi, flat screen TVs, and comfortable recliners. Feel free to bring a friend or family member with you. At Infusion Express taking care of you is our number one priority. We are committed to making you better in a better way!

Lubbock Artificial Limb Co Inc

Lubbock Artificial Limb Co Inc is a Lubbock, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Fermatex

Fermatex Vascular Technologies, LLC is an industry-leading designer and manufacturer of high pressure braided tubing, complex medical extrusions and advanced catheters used throughout the medical device industry.

Recovery Force

Recovery Force is an innovative medical device company providing healthcare professionals, patients, and athletes with a next-generation mobile compression solution for enhancing circulation. The company has developed a platform technology with the ability to embed shape-changing memory fibers into various types of garments and footwear to produce therapeutic compressions. Recovery Force`s portfolio includes medical devices that will reduce post-operative pain, swelling and wound healing time; treat chronic lymphedema; prevent blood clots (DVT); and alleviate joint pain and sore muscles. The same technology used in healthcare is also available to sports enthusiasts and athletes, providing enhanced circulation during warm-up and recovery to achieve optimal performance.

MIVI Neuroscience

MIVI Neuroscience, (MIVI) is an innovative medical device company that aims to achieve life-giving results for an increasing number of patients experiencing acute ischemic stroke (AIS).